Inquiry Basket
Loading ......
Filter By Product Search for
PTGS2
PTGS2 Full Name
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
PTGS2 Introduction
PTGS2, also widely known as cyclooxygenase-2 (COX-2), is a highly inducible enzyme that plays a central role in prostaglandin biosynthesis during inflammation, tissue injury, and immune activation. Unlike the constitutively expressed PTGS1/COX-1 enzyme that supports normal physiological homeostasis, PTGS2 is rapidly upregulated in response to cytokines, growth factors, oxidative stress, infection, and cellular damage. This gene has become one of the most intensively studied therapeutic targets because abnormal PTGS2 activity is closely linked to chronic inflammation, pain, fever, vascular dysfunction, and tumor progression. For researchers and drug developers, PTGS2 remains especially important due to its direct connection with widely used nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors. Increasing evidence also shows that PTGS2 signaling extends far beyond inflammation alone, influencing reproductive biology, immune regulation, angiogenesis, and early embryonic development, making it a critical molecular bridge between normal physiology and disease pathology.
Functionally, PTGS2 catalyzes the conversion of arachidonic acid into prostaglandin intermediates that are further processed into bioactive lipid mediators such as prostaglandin E2 (PGE2). These downstream molecules regulate diverse biological processes including inflammatory signaling, vascular permeability, nociception, ovulation, fertilization, and tissue repair. Recent studies have highlighted the complexity of the PTGS2/PGE2 signaling cascade, particularly its context-dependent effects in immune and metabolic disorders. In type 1 diabetes mellitus, for example, PTGS2-derived PGE2 has demonstrated both protective and damaging effects on pancreatic β-cells depending on the inflammatory microenvironment and receptor engagement. Emerging mechanistic research has further revealed that endothelial regulatory proteins such as ROBO4 can suppress PTGS2 expression through RAC1-associated signaling pathways, thereby reducing vascular inflammation, edema, and inflammatory tissue injury. These findings are reshaping how scientists view PTGS2—not simply as a pro-inflammatory enzyme, but as a tightly regulated signaling hub whose biological impact depends on cell type, disease stage, and surrounding immune conditions.
PTGS2 is strongly associated with numerous human diseases, particularly inflammatory disorders, autoimmune diseases, cardiovascular complications, neurodegeneration, and cancer. Elevated PTGS2 expression has been detected in colorectal cancer, breast cancer, lung cancer, melanoma, and many other solid tumors, where the COX-2/PGE2 axis contributes to tumor growth, angiogenesis, immune evasion, and metastatic progression. Within the tumor microenvironment, PTGS2-driven prostaglandin signaling through EP2 and EP4 receptors can suppress antitumor immunity and support cancer cell survival, making this pathway an attractive target for next-generation immuno-oncology strategies. Beyond oncology, dysregulated PTGS2 activity has been implicated in arthritis, inflammatory bowel disease, atherosclerosis, reproductive disorders, and chronic pain syndromes. Because PTGS2 expression is highly responsive to inflammatory stimuli and environmental stress, it is frequently used as a biomarker for disease activity and therapeutic response in both preclinical and clinical research. Ongoing efforts to develop safer and more selective PTGS2-targeted therapies continue to attract significant interest, especially as researchers seek to balance anti-inflammatory efficacy with cardiovascular and gastrointestinal safety concerns.
Alternate Names for PTGS2
PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase); COX2; COX-2; PHS-2; PGG/HS; PGHS-2; hCox-2; GRIPGHS; prostaglandin G/H synthase 2; PHS II; PGH synthase 2; cyclooxygenase 2b; prostaglandin H2 synthase 2;
Loading ......
